Circulating Biomarker Results From a Phase 2 Study of Seralutinib in Pulmonary Arterial Hypertension

  • Osterhout, R.
  • Boucly, A.
  • Benza, R. L.
  • Channick, R. N.
  • Chin, K. M.
  • Frantz, R. P.
  • Hemnes, A. R.
  • Howard, L. S.
  • McLaughlin, V. V.
  • Sitbon, O.
  • Vachiery, J. L.
  • Zamanian, R. T.
  • Aranda, R.
  • Cravets, M.
  • Ding, Z.
  • Duong-Verle, T.
  • Mottola, D.
  • Roscigno, R. F.
  • Sitapara, R.
  • Zisman, L. S.
  • Bruey, J. M.
  • Ghofrani, H. A.

Keywords

  • Hemodynamics
  • Inflammation Mediators
  • Molecular Mechanisms of Pharmacological Action
  • Tyrosine Kinase Inhibitor
  • Vascular Remodeling
Publication details
DOI: 10.1093/ajrccm/aamag175
Journal: Am J Respir Crit Care Med
Work Type: Original
Access number: 42104009
See publication on PubMed
More information
chevron-down